Apyx Medical Corporation (APYX) Financials
APYX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 70.7 million | 50.3 million |
2023-12-31 | 79.2 million | 52.3 million |
2023-09-30 | 59.4 million | 25.9 million |
2023-06-30 | 62.4 million | 25.7 million |
APYX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -6.4 million | 1.1 million |
2023-12-31 | -551000 | 914000 |
2023-09-30 | 3.5 million | 1.4 million |
2023-06-30 | -5.0 million | 1.5 million |
APYX Net Income
No data available :(
APYX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 37.3 million | - | 5.2 million |
2023-12-31 | 43.7 million | - | 5.3 million |
2023-09-30 | 22.1 million | - | 5.4 million |
2023-06-30 | 18.5 million | - | 5.5 million |
APYX Shares Outstanding
APYX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 35000 | 1.4 million | 11.2 million | - |
2023-12-31 | 93000 | 1.2 million | 13.5 million | 4.9 million |
2023-09-30 | 174000 | 1.3 million | 11.3 million | 6.5 million |
2023-06-30 | 156000 | 1.2 million | 12.0 million | - |
APYX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 14.5 million | 8.6 million |
2023-12-31 | 14.7 million | 10.6 million |
2023-09-30 | 16.0 million | 8.0 million |
2023-06-30 | 13.6 million | 4.3 million |
APYX
Price: $1.66
52 week price:
Earnings Per Share: -0.54 USD
P/E Ratio: -6.12
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 194062
Market Capitalization: 49.5 million